PRDX1 and neoplasm: Binding of Prx1 to TLR4 stimulates release of pro-inflammatory cytokines interleukin (IL)-6 and tumor necrosis factor (TNF)-α from macrophages [15] and VEGF from tumor cells, macrophages and endothelial cells [13].